Type
. Isothermal amplification and molecular typing of the obligate intracellular pathogen Mycobacterium leprae isolated from tissues of unknown origins. Journal of clinical microbiology [Internet]. 2006;44(4):1502-8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1448671/pdf/1524-05.pdf
Type
. Synthesis and antileprosy activity of some dialkyldithiocarbamates. The Journal of antimicrobial chemotherapy. 2006;57(6):1134-8.
Type
. DC-SIGN association with the Th2 environment of lepromatous lesions: cause or effect?. The Journal of pathology. 2006;209(2):182-9.
Type
. Anti-neutrophil cytoplasmic antibodies in leprosy. Clinical rheumatology. 2007;26(2):208-10.
Type
. Bactericidal activities of R207910 and other newer antimicrobial agents against Mycobacterium leprae in mice. Antimicrobial agents and chemotherapy. 2006;50(4):1558-60.
Type
. Leprosy in Mexico. Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association. 2006;75(1):51-8.
Type
. [Situation of global leprosy]. Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association. 2006;75(1):41-9.
Type
. [Future strategies for global leprosy control]. Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association. 2006;75(1):23-39.
Type
. [Leprosy and medicine I--proposal of an isolation policy and its background]. Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association. 2006;75(1):3-22.
Type
. Treatment of leprosy: science or politics?. Tropical medicine & international health : TM & IH [Internet]. 2006;11(3):268-78. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-3156.2006.01561.x/pdf